Rheumatoid arthritis confirmed by positive rheumatoid factor, affecting a site not individually enumerated in the M05.7 subcategory, with no documented organ or systemic involvement.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M05.7A.
Source · Editorial brief grounded in 6 cited references ↓
- Explicitly name the affected joint in the note — 'temporomandibular joint,' 'sternoclavicular joint,' etc. — so that 'other specified site' is defensible and auditable.
- Record the positive rheumatoid factor result (lab value or prior confirmed seropositivity) in the assessment or problem list; M05.7A requires RF-positive status.
- Confirm and document the absence of organ or systemic involvement (e.g., 'no pulmonary, cardiac, or vascular manifestations of RA') to justify the 'without organ or systems involvement' qualifier.
- If the patient is on DMARDs or biologics, note the treatment regimen — payers and risk-adjustment models use this to corroborate active seropositive RA.
- For surgical encounters, the operative report should state the joint operated on by name; do not rely solely on the CPT code to establish site specificity for the diagnosis.
Related CPT procedures
Procedure codes commonly billed with M05.7A. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M05.7A and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M05.70 (unspecified site) when the chart clearly names the affected joint — M05.7A requires a documented 'other specified' site, but if the site is named and doesn't match M05.711–M05.79, M05.7A is the correct pick.
- Using M05.7A when organ or systemic involvement is documented elsewhere in the record — extra-articular RA manifestations (lung, heart, eye, vasculitis) push the code to M05.0–M05.5 subcategories.
- Assigning M05.7A when rheumatoid factor positivity is not confirmed by lab testing; seronegative or unspecified-serology RA belongs in the M06.- category.
- Confusing M05.7A with M05.79 (multiple sites) — use M05.79 when two or more distinct joints are actively involved, not M05.7A for a single atypical site.
- Failing to update the diagnosis code when a patient's disease progresses to include systemic involvement; periodic chart review should trigger a code revision from M05.7A to the appropriate organ-involvement subcategory.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M05.7A applies when the treating provider documents seropositive rheumatoid arthritis (positive rheumatoid factor) localized to a joint or anatomical site that doesn't have its own dedicated code under M05.71–M05.79 (shoulder, elbow, wrist, hand/finger, hip, knee, ankle/foot, or vertebrae). Typical 'other specified' sites include the temporomandibular joint, acromioclavicular joint, or sternoclavicular joint. The 'without organ or systems involvement' restriction is critical — if the record documents extra-articular manifestations such as rheumatoid lung disease, vasculitis, pericarditis, or Felty syndrome, this code is excluded in favor of codes from M05.0–M05.5.
M05.7A was introduced as a new code in FY2021 to close the gap left by the unspecified-site code M05.70. Use M05.7A only when the affected site is explicitly documented and confirmed to be seropositive (RF+). If the site is unspecified, use M05.70. If multiple joints are involved, consider M05.79 (multiple sites). If RF status is not confirmed by lab, drop to M06.- (other rheumatoid arthritis, seronegative).
In orthopedic practice, this code surfaces most often when a patient with known seropositive RA presents for surgical management — synovectomy, joint reconstruction, or arthroplasty — of a less common joint. Because payers may flag the 'other specified' designation without clear documentation of the site, the operative or clinic note must name the exact joint involved.
Sibling codes
Other billable codes under M05.7 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What makes a site qualify as 'other specified' for M05.7A?
02Can I use M05.7A if the patient also has rheumatoid lung disease?
03What is the difference between M05.7A and M05.70?
04Does M05.7A require a 7th-character extension?
05When was M05.7A added to ICD-10-CM?
06Should M05.7A or M06.- be used when RF status is unknown?
07How does M05.7A interact with CPT codes for surgical procedures on atypical RA joints?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M05-/M05.7A
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M05.7A
- 04rhinomds.comhttps://rhinomds.com/m05-icd-10-codes-for-rheumatoid-arthritis-2026-a-billing-coding-guide/
- 05healthcareinspiredllc.comhttps://healthcareinspiredllc.com/rheumatoid-arthritis-factor-or-not/
- 06allzonems.comhttps://www.allzonems.com/blogs/icd-10-musculoskeletal-coding-guide/
Mira AI Scribe
Mira's AI scribe captures the specific joint name, confirmed RF-positive lab status, and explicit absence of organ or systemic involvement from the encounter note. That documentation locks in M05.7A over the less-specific M05.70, preventing a payer downcode and protecting against audit flags that challenge 'other specified' site claims lacking a named anatomical location.
See how Mira captures M05.7A documentation